Aptus Value Housing Finance India Limited (NSE:APTUS)
India · Delayed Price · Currency is INR | Market Cap | 169.23B |
| Revenue (ttm) | 13.07B |
| Net Income (ttm) | 7.99B |
| Shares Out | 499.94M |
| EPS (ttm) | 15.97 |
| PE Ratio | 21.19 |
| Forward PE | 17.83 |
| Dividend | 4.50 (1.37%) |
| Ex-Dividend Date | May 16, 2025 |
| Volume | 4,749,809 |
| Average Volume | 1,727,478 |
| Open | 329.00 |
| Previous Close | 327.65 |
| Day's Range | 327.65 - 353.80 |
| 52-Week Range | 267.95 - 401.65 |
| Beta | 0.44 |
| RSI | 50.95 |
| Earnings Date | Aug 1, 2025 |
About Intra-Cellular Therapies
Aptus Value Housing Finance India Limited, together with its subsidiary, Aptus Finance India Private Limited, provides housing finance solutions in India. The company offers home and quasi-home loans for the purchase, construction, renovation, and extension of houses; loans against property for construction and purchase of houses; and secured, small business, and refinance loans. It also provides life, credit shield, and property insurance products. The company serves individual homebuyers; low and middle income salaried and self-employed indiv... [Read more]
Financial Performance
In 2024, NSE:APTUS's revenue was 12.29 billion, an increase of 22.98% compared to the previous year's 10.00 billion. Earnings were 7.51 billion, an increase of 22.77%.
Financial StatementsNews
Aptus Value Housing Finance shares surge over 9% to hit all-time high
Aptus Value Housing Finance India shares surged by over 9% on October 14 following a surge in trading volumes. As of 10:10 AM, the stock was trading at ₹393.60, up ₹32.80 or 9.09% from the previous cl...